Evidence that the apparent complexity of receptor antagonism by angiotensin II analogues is due to a reversible and syntopic action

British Journal of Pharmacology
Y J LiuJ W Black


1. The interactions between angiotensin II (AII), two non-peptide antagonists DuP 753 and IMI, and eight peptide analogues of AII were investigated on the rabbit isolated aorta assay. DuP 753 and IMI behaved as simple competitive antagonists (pKB values 8.4 and 6.8, respectively). To different degrees, all the AII-peptide analogue interactions failed to meet the basic criteria for simple competition. In addition to rightward shift, the most significant feature was a concentration-dependent saturable depression of the upper asymptote of the AII concentration-effect curves. 2. 'Washout' and combined dose-ratio analysis experiments, in which DuP 753 was used as a reference antagonist, indicated that the profile of peptide antagonism was solely due to a reversible and syntopic action at the AII receptor. 3. By use of an operational model of agonism (Black & Leff, 1983) as a starting point, it was possible to account for the data with a new model which describes reversible receptor occupancy and occupied receptor-determined, saturable reduction in the efficacy of AII. Model-fitting gave estimates of pKB values for the peptide analogues and agonist affinity and efficacy parameters for AII. 4. The model was successfully tested by appl...Continue Reading


Feb 1, 1991·Trends in Pharmacological Sciences·P B TimmermansW F Herblin
Jun 15, 1990·Biochemical and Biophysical Research Communications·L CriscioneB Kamber
Nov 1, 1985·British Journal of Pharmacology·J W Black, N P Shankley
May 15, 1989·Biochemical and Biophysical Research Communications·M HolckE Escher
Jun 1, 1986·Endocrinology·C BianchiM Cantin
Feb 1, 1987·Naunyn-Schmiedeberg's Archives of Pharmacology·T P Kenakin, D Beek
Mar 1, 1970·Journal of Medicinal Chemistry·P A KhairallahF M Bumpus
Nov 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·G R MarshallP Needlemann
Sep 29, 1972·Science·R K TürkerF M Bumpus
Dec 22, 1983·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·J W Black, P Leff
Aug 8, 1980·European Journal of Pharmacology·R J FreerA R Day
Apr 1, 1964·British Journal of Pharmacology and Chemotherapy·H P RANG

❮ Previous
Next ❯


Oct 1, 1994·Trends in Pharmacological Sciences·M J RobertsonP Leff
Jan 1, 1995·Peptides·L J MachadoC C Coimbra
Apr 27, 2001·Biochemical Pharmacology·F L FierensaG Vauquelin
Jul 8, 1999·European Journal of Pharmacology·F L FierensG Vauquelin
Nov 11, 1999·European Journal of Pharmacology·A ChristopoulosE E El-Fakahany
Oct 26, 2000·Trends in Pharmacological Sciences·M J LewA Christopoulos
Jul 20, 2001·Trends in Pharmacological Sciences·G VauquelinP Vanderheyden
Mar 10, 2001·Clinical and Experimental Pharmacology & Physiology·A Christopoulos
Feb 7, 2003·Fundamental & Clinical Pharmacology·G VauquelinP M L Vanderheyden
Jan 1, 1994·British Journal of Pharmacology·A HilditchM J Robertson
Jun 21, 2001·The Journal of Clinical Hypertension·D A Sica
Jun 4, 1999·Journal of Clinical Pharmacology·M M McConnaugheyA J Ingenito
Mar 1, 2001·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Georges VauquelinPatrick Ml Vanderheyden
Apr 23, 2002·Journal of the Renin-angiotensin-aldosterone System : JRAAS·P M VanderheydenG Vauquelin
Dec 3, 2010·The Journal of Pharmacology and Experimental Therapeutics·Mami OjimaHideaki Nagaya
Jun 19, 2007·The Journal of Pharmacology and Experimental Therapeutics·Erik LindströmGeorges Vauquelin
Aug 17, 2002·The Journal of Pharmacology and Experimental Therapeutics·Marc P MaillardMichel Burnier
Jul 19, 2000·American Journal of Physiology. Heart and Circulatory Physiology·T R Nurkiewicz, M A Boegehold
Apr 1, 2011·British Journal of Pharmacology·Simeon J RamseyPiet H van der Graaf

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.